PRPO

MKT CAP:$42M

Precipio Inc

Market Cap

$42M

Healthcare·Diagnostics & Research·🇺🇸 United States·NASDAQ

Healthcare·Diagnostics·🇺🇸·NASDAQ

Stock Price

$23.49-$0.33 (-1.39%)

Jun 5, 2026

52W High $32.3752W Low $10.66

Company Details

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust gen...

CEO

—

IPO Date

Jul 18, 2000

Website

www.precipiodx.com

Key Metrics TTM

Revenue

$26M

+34.8% YoY

Net Income

-$922.0K

EPS (Diluted)

Free Cash Flow

$555.0K

Revenue / Share

$14.63

Gross Margin

43.3%

Operating Margin

-6.8%

Net Margin

-3.5%

FCF Margin

2.1%

P/S

1.6x

P/E

Earnings Reports

Q1 2026

May 14, 2026

$6M+48.0%

FY 2025

Mar 30, 2026

$24M+50.6%

Q4 2025

Mar 30, 2026

$8M+46.3%

Q3 2025

Nov 14, 2025

$6M+18.3%

Q2 2025

Aug 13, 2025

$6M+27.3%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee